BIOEQUIVALENCE STUDIES OF MARKETED CLOZAPINE TABLETS BY USING OPTIMIZED VALIDATED LIQUID CHROMATOGRAPHIC METHOD
Objective: A simple, selective, precise and accurate method was developed for the estimation of Clozapine by RP-HPLC technique.
Methods: Chromatographic conditions used are stationary phase, Phenomenex BDS (150 mm x 4.6 mm, 5Âµ), Mobile phase was methanol and water in (80:20) ratio and flow rate was maintained at 1.0 ml/min, column temperature was set at 25 Â°C, detection wavelength was 240 nm, and diluent was mobile phase. These conditions were finalized for the optimized method.
Results: Linearity study was carried out between 10-60 Âµg/ml, the R2 value was found to be as 0.995. Precision was found to be as follows for system precision 1.052, method precision 1.662, and intraday precision 1.02 and for interday precision 0.93. The % Recovery was found to be 98.60%. LOD and LOQ were found to be 2.7 Âµg/ml and 8.4 Âµg/ml respectively. By using the above method assay of the marketed formulation was carried out and the % purity was found to be 99.28 %. Stability studies of Clozapine were done, in all conditions degradation was found to be within the acceptable range.
Conclusion: The current validated method was finally applied in bioequivalence studies of four different brands of Clozapine by using dissolution apparatus and percentage drug release was found to be 99.48%, it was within the acceptable limit (NLT 85 %) as per USP.
2. Kaur H, Bassi P, Monif T, Khuroo A, Kaur G. Development and validation of high performance liquid chromatographic method for analysis of clozapine. Pak J Pharm Sci 2013;26:465-72.
3. Uma A Patil, Bijaya Ghosh. Reverse phase liquid chromatographic method for the estimation of clozapine from tablet dosage forms. Int J PharmTech Res 2009;1:733-6.
4. Chokchai Wongsinsup, Wandee Taesotikul, Sayam Kaewvichit, Siriluk Sangsrijan, Saowarunee Sangsrijan. Determination of clozapine in human plasma by highâ€“performance liquid chromatography with UVâ€“VIS detector. CMU J Nat Sci 2010;9:29-37.
5. Emrah Dural, Gorkem Mergen, Tulin Soylemezoglu. Optimization and validation of an HPLC-UV method for analysis of clozapine and its major metabolites in human plasma. Turk J Pharm Sci 2015;12:177-86.
6. MA Raggi, F Bugamelli, R Mandrioli, D De Ronchi, V Volterra. Development and validation of an HPLC method for the simultaneous determination of clozapine and desmethylclozapine in plasma of schizophrenic patients. Chromatographia 1999;49:75â€“80.
7. ICH Harmonised Tripartite guidelines: validation of analytical procedures: text and methodology Q2(R1); 1996. p. 1-13.
8. ICH harmonized tripartite guideline stability testing. Photostability testing of new drug substances and products: Q1B Current Step 4 version dated 6 November; 1996.
9. Trivikram Rawat, IP Pandey. Forced degradation studies for drug substances and drug products-scientific and regulatory considerations. Int J Pharm Sci Res 2015;7:238-41.
10. MS Charde. Jitendra Kumar AS, Welankiwar R, D Chakole. Development of forced degradation studies of drugs. Int J Adv Pharm 2013;2:159-65.